The article starts by highlighting the huge potential of medical device market in Asia and the Asia expansion plan of idsMED.
The medical device industry is developing rapidly especially in Asia. Revenue of idsMED, a global medical product distributor and management company under Fung Investments, multiplied four times in four years. The company is positive on the market potentials in Asia and expected to continue its growth in Asia through merger and acquisition.
idsMED is now operating in eight markets including Hong Kong, Taiwan and other Southeast Asia countries. Ben Chang, CEO of idsMED, said the global growth rate of medical industry already reaches two to three times of the GDP, which is not comparable by other industries. The Asia market potential is especially not to be sniffed at.
Build multi-national distributing network to reduce cost of sales
Since its founding in 2011, idsMED’s annual growth rate is maintained at 30%. Chang said the huge population in Asia will continue to drive up the demand for quality yet affordable medical service, while the medical device supply chain in Asia needs to improve.
Unlike other general consumables, the undeveloped medical supply chain leads to higher inventory cost and longer lag time from order confirmation to product delivery. idsMED can shorten the product delivery time from 5-6 months to 2-3 months by improving the supply chain operation. Through building multi-national distributing network, idsMED optimises the supply chain which will eventually reduce the cost of sales.
Eye on M&A, aim to enter China and India markets
For long term, Chang said he expected the pricing and deliverability of medical devices could be comparable with fast moving consumer goods through supply chain optimisation, while the sales of medical devices should couple with maintenance and repair services and also technical training.
idsMED envisioned to double its size in the next three to four years and expand from the current eight operating markets to 18 - including China and India in its future territory. idsMED hopes to list in Hong Kong or Singapore in the next three to five years.
To open online shop eyeing for huge potentials of the elderly market
A side bar on idsMED as a company focusing on medical product distribution and management under Fung Investments, might open an online shop for medical products in view of the huge market potentials for elderly products.
For original reference, you can see the article here
***
Hong Kong Economic Times
醫療設備分銷商 生意4年飈4倍
2017-07-27
A14 | 工商 | By 李素瑩
全球醫療產業高速發展，尤以亞洲市場為甚。馮氏投資旗下醫療產品分銷及管理公司idsMED於過去4年間，營業額增長4倍，該公司看好亞洲市場潛力，冀於未來數年透過併購續拓區內市場。
idsMED現時經營東南亞6個國家及香港和台灣市場，其行政總裁鄭有德指出，全球醫療產業的增長速度已是GDP增幅的2至3倍，醫療開支現已佔全球GDP的11%，增速是其他行業難以比擬，尤以亞洲市場的潛力不容小覷：「亞洲人的年均醫療開支是300至400美元，美國人是9,000美元，當然美國的醫療是很貴，而歐洲亦達3,000美元，由此可見亞洲的增長空間。」
建多國分銷網 降銷售成本
idsMED自2011年成立以來，業務保持30%的年增長，鄭氏認為，亞洲人口眾多，並對優質且低價的醫療服務需求不斷增長，惟區內的醫療設備供應鏈有待完善。
有別於一般消費品，醫療設備在亞洲區內的分銷商不多，醫院直接向生產商購買產品，由下單至收貨往往需要5至6個月。鄭氏指出，供應鏈未被發展，長達5至6個月的交貨時間使分銷商需要囤積大量庫存，風險高。
鄭氏又指，idsMED並不囤積庫存，而是透過改善供應鏈的運作，把交貨時間縮短到2至3個月。他表示，分銷量的提升是優化供應鏈的重要因素，亞洲區內現時不乏優質的醫療產品商，卻以其國內市場為主，對出口的知識欠奉，跨國公司幾乎不存在。idsMED透過建立多國分銷網絡，得以優化供應鏈，並有助降低產品銷售成本。
擬作併購 盼進軍中印市場
長遠而言，他期望供應鏈的優化可使醫療設備的定價和供應能力，媲美快速消費品，惟同時強調醫療設備有別於一般消費品，銷售需配合維修保養服務，乃至為購買者提供技術培訓：「購買前可能已花了1年做培訓。」
idsMED擬於未來3至4年內把市場規模，由現時8個地區擴充1倍至16個，包括拓展中國和印度等人口眾多的市場。
近年有不少外資企業透過併購中國的醫療企業作為進入當地市場的捷徑，他坦言idsMED現時在多個國家也有一些企業名單擬對其作出收購。他又期望，idsMED可於未來3至5年在香港或新加坡上市。
Hong Kong Economic Times
銀髮族潛力大 擬開網店
2017-07-27
A14 | 工商 | By 李素瑩
網購發展成為全球消費市場新焦點，馮氏投資旗下醫療產品分銷及管理公司idsMED，看好醫療產品銷售在電子商務的發展，不排除於未來數年開設醫療產品網店。
醫療產業網購 料快速發展
idsMED行政總裁鄭有德指出，多個行業現時已積極發展網上市場，惟醫療產業在有關領域卻相對落後，但相信未來5年將會加速發展。他稱，日本的銀髮網購市場已甚具規模，消費者開始於網上選購長者用品：「人生有90%的醫療開支都集中在65歲後，銀髮市場潛力大。」
鄭又表示，亞洲多國的人口老化問題，正好為醫療服務提供者帶來機遇，idsMED擬於未來數年開拓網上市場，並有意開設網店，又認為有需要加強向公眾推廣醫療產品知識，以便拓展市場。
